Inhibition of SPATS2L in AML cells could suppress cell growth, induce cell apoptosis, suppress JAK2, STAT3, and STAT5 expression, and enhance the pro-apoptotic effects of AML chemotherapy drugs. This evidence concerns the gene JAK2 and acute myeloid leukemia.